Literature DB >> 8735294

Long-term follow-up of women with borderline ovarian tumors.

S Kehoe1, J Powell.   

Abstract

OBJECTIVE: To examine the long-term survival of patients with borderline ovarian carcinomas.
METHOD: A population-based retrospective analysis of patients registered with West Midlands Regional Cancer Registry. The files of all patients registered with ovarian carcinoma during the triennium 1985-1987 were examined and those with borderline ovarian carcinomas identified.
RESULTS: During the period, 1654 patients were registered, of whom 1344 had histologically confirmed ovarian carcinoma. From these 54 (4%) patients had borderline tumors--all Stage I or II. Follow-up ranged from 5 to 10 years, with only 2 patients identified where death was due to recurrent ovarian malignancy.
CONCLUSIONS: Epidemiological studies avoid the bias associated with hospital-based series, and enable a crude evaluation of practice standards. From this series certain areas were identified where management could be improved. Thus the information gleaned can be utilized to address such issues, and comparative studies performed in the future to assess the impact of any changes made. The series confirms the excellent prognosis associated with early stage borderline ovarian carcinomas.

Entities:  

Mesh:

Year:  1996        PMID: 8735294     DOI: 10.1016/0020-7292(95)02642-8

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

1.  HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis.

Authors:  Sang Kyum Kim; Nam Hoon Cho
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis.

Authors:  Sang Kyum Kim; Si Young Song; Sunghoon Kim; Nam Hoon Cho; Ga Won Yim; Sang Wun Kim; Young Tae Kim; Eun Ji Nam
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 3.  Controversies in borderline ovarian tumors.

Authors:  Seok Ju Seong; Da Hee Kim; Mi Kyoung Kim; Taejong Song
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.